Showing results (151-160 of 447) with videos related to
Sort By:
Pageof 45
Annals of Internal Medicine|January 4, 2007
Narrative review: reversible cerebral vasoconstriction syndromesLeonard H Calabrese, David W Dodick, Todd J Schwedt, et al.Current Atherosclerosis Reports|August 19, 2008
Migraine with and without aura and risk for cardiovascular diseaseBert B Vargas, David W Dodick, Dean M Wingerchuk, et al.Cephalalgia : an International Journal of Headache|July 25, 2020
The migraine landscape on YouTube: A review of YouTube as a source of information on migraineHillah Saffi, Thien Phu Do, Jakob Møller Hansen, et al.Headache|November 9, 2020
Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After DosingDavid W Dodick, Christopher Gottschalk, Roger Cady, et al.Headache|February 10, 2019
The Spectrum of Vestibular Migraine: Clinical Features, Triggers, and Examination FindingsShin C Beh, Shamin Masrour, Stacy V Smith, et al.Neurology. Clinical Practice|December 20, 2018
Clinical characteristics of Alice in Wonderland syndrome in a cohort with vestibular migraineShin C Beh, Shamin Masrour, Stacy V Smith, et al.Cephalalgia : an International Journal of Headache|July 4, 2020
Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headacheEdita Navratilova, Sasan Behravesh, Janice Oyarzo, et al.Headache|March 29, 2021
Impact of abuse on migraine-related sensory hypersensitivity symptoms: Results from the American Registry for Migraine ResearchMeesha Trivedi, Gina Dumkrieger, Catherine D Chong, et al.Cephalalgia : an International Journal of Headache|July 25, 2020
Googling migraine: A study of Google as an information resource of migraine managementRachid Bojazar, Thien Phu Do, Jakob Møller Hansen, et al.Headache|April 20, 2005
Duration of migraine is a predictor for response to botulinum toxin type AEric J Eross, Jonathan P Gladstone, Susan Lewis, et al.Pageof 45